TFA
MXCT icon

Transamerica Financial Advisors’s MaxCyte MXCT Stock Holding History

Transamerica Financial Advisors’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$230 Hold
187
– – ﹤0.01% 1849
2026
Q1 		$131 Buy
+187
New +$175 ﹤0.01% 1705
2025
Q4 		– Sell
-94
Closed -$149 – 1887
2025
Q3 		$149 Buy
+94
New +$163 ﹤0.01% 1479

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Transamerica Financial Advisors's MXCT Position: Q2 2026 in Review

Transamerica Financial Advisors held its MaxCyte (MXCT) position steady in Q2 2026 at 187 shares worth $230. The position accounts for ﹤0.01% of the portfolio, ranked #1849.

Transamerica Financial Advisors first reported a position in MXCT in Q3 2025 and has held it in 3 quarters since. 123 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Transamerica Financial Advisors held 187 shares of MaxCyte worth $230 as of Q2 2026.
  • Transamerica Financial Advisors left its MaxCyte share count unchanged in Q2 2026.
  • MaxCyte made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1849 holding.
  • Transamerica Financial Advisors first reported a position in MaxCyte in Q3 2025 and has held it in 3 quarters since.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.